TV News LIES

Sunday, Apr 20th

Last update02:58:40 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Judge overturns strict N.D. anti-abortion law

ND abortion law overturnedA federal judge Wednesday overturned as unconstitutional a North Dakota law banning abortions as early as...

Tamiflu: Millions wasted on flu drug, claims major UK report

TamifluHundreds of millions of pounds may have been wasted on a drug for flu that works...

Researchers speak to new study exposing link between SSRIs and autism

SSRIResearchers at Johns Hopkins Bloomberg School of Public Health are calling attention to a new study...

Study: E-cigarettes affect cells similarly to regular tobacco

e-cigsA new study shows that the vapor from e-cigarettes damages human cells similarly to smoke from...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!